| Identification | Back Directory | [Name]
PSMA-617 | [CAS]
1702967-37-0 | [Synonyms]
PSMA-617
Vipivotide tetraxetan
L-Lysine, N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-N6-[3-(2-naphthalenyl)-N-[[trans-4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]methyl]cyclohexyl]carbonyl]-L-alanyl]- | [Molecular Formula]
C49H71N9O16 | [MDL Number]
MFCD31715458 | [MOL File]
1702967-37-0.mol | [Molecular Weight]
1042.14 |
| Chemical Properties | Back Directory | [Boiling point ]
1371.9±65.0 °C(Predicted) | [density ]
1.322±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Water:150.0(Max Conc. mg/mL);100.13(Max Conc. mM)
DMSO:125.0(Max Conc. mg/mL);83.43(Max Conc. mM) | [form ]
Solid | [pka]
1.83±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
PSMA-617 has been used in prostate cancer research, and is a promising prostate-specific membrane antigen-targeted theranostic agent. | [storage]
Store at -20°C |
|
| Company Name: |
csynbio Gold
|
| Tel: |
15051477682 |
| Website: |
m.is0513.com/showsupplierproductslist1949820/0.htm |
|